-+ 0.00%
-+ 0.00%
-+ 0.00%

Nuwellis Aquadex registry shows 86% of pediatric cases with complete data reach planned treatment duration

PUBT·11/19/2026 13:31:52
Listen to the news
Nuwellis Aquadex registry shows 86% of pediatric cases with complete data reach planned treatment duration
  • Nuwellis will discuss ULTRA-Peds registry results for its Aquadex device in pediatric patients at a December 1, 2026, webinar.
  • Most treatments with complete data lasted their planned duration; early circuit terminations mainly involved vascular access problems or clotting.
  • The multicenter study, accepted for publication in Pediatric Nephrology, evaluated Aquadex use in critically ill infants and children.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611190830PRIMZONEFULLFEED9880830) on November 19, 2026, and is solely responsible for the information contained therein.